0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Measle Vaccine Market Insights and Forecast to 2028
Published Date: January 2022
|
Report Code: QYRE-Auto-27P9049
Home | Market Reports | Health | Health Conditions | Infectious Diseases
Global Measle Vaccine Market Insights and Forecast to 2028

Global Measle Vaccine Market Insights and Forecast to 2028

Code: QYRE-Auto-27P9049
Report
January 2022
72 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Measles vaccine is made by inoculation of attenuated strain of measles virus into chicken embryo cells, culture and harvesting of virus venom, and then freeze-drying. Injection into the lateral deltoid muscle attachment of the upper arm can prevent measles.
Market Analysis and Insights: Global Measle Vaccine Market

Due to the COVID-19 pandemic, the global Measle Vaccine market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period.

Fully considering the economic change by this health crisis, Inactivated Vaccine accounting for % of the Measle Vaccine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Hospital segment is altered to an % CAGR throughout this forecast period.
China Measle Vaccine market size is valued at US$ million in 2021, while the US and Europe Measle Vaccine are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Measle Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

The global key manufacturers of Measle Vaccine include Merck, Biovac and McKesson Medical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Measle Vaccine Scope and Segment
Measle Vaccine market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Measle Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Inactivated Vaccine
Attenuated Vaccine

Segment by Application

Hospital
Scientific Research
Others

BY COMPANY

Merck
Biovac
McKesson Medical

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
1 Study Coverage
1.1 Measle Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Measle Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Inactivated Vaccine
1.2.3 Attenuated Vaccine
1.3 Market by Application
1.3.1 Global Measle Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Scientific Research
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Measle Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Measle Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Measle Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Measle Vaccine Sales by Region
2.4.1 Global Measle Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Measle Vaccine by Region (2023-2028)
2.5 Global Measle Vaccine Revenue by Region
2.5.1 Global Measle Vaccine Revenue by Region (2017-2022)
2.5.2 Global Measle Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Measle Vaccine Sales by Manufacturers
3.1.1 Global Top Measle Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Measle Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Measle Vaccine in 2021
3.2 Global Measle Vaccine Revenue by Manufacturers
3.2.1 Global Measle Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Measle Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Measle Vaccine Revenue in 2021
3.3 Global Measle Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Measle Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Measle Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Measle Vaccine Sales by Type
4.1.1 Global Measle Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Measle Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Measle Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Measle Vaccine Revenue by Type
4.2.1 Global Measle Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Measle Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Measle Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Measle Vaccine Price by Type
4.3.1 Global Measle Vaccine Price by Type (2017-2022)
4.3.2 Global Measle Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Measle Vaccine Sales by Application
5.1.1 Global Measle Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Measle Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global Measle Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Measle Vaccine Revenue by Application
5.2.1 Global Measle Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Measle Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Measle Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Measle Vaccine Price by Application
5.3.1 Global Measle Vaccine Price by Application (2017-2022)
5.3.2 Global Measle Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Measle Vaccine Market Size by Type
6.1.1 North America Measle Vaccine Sales by Type (2017-2028)
6.1.2 North America Measle Vaccine Revenue by Type (2017-2028)
6.2 North America Measle Vaccine Market Size by Application
6.2.1 North America Measle Vaccine Sales by Application (2017-2028)
6.2.2 North America Measle Vaccine Revenue by Application (2017-2028)
6.3 North America Measle Vaccine Market Size by Country
6.3.1 North America Measle Vaccine Sales by Country (2017-2028)
6.3.2 North America Measle Vaccine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Measle Vaccine Market Size by Type
7.1.1 Europe Measle Vaccine Sales by Type (2017-2028)
7.1.2 Europe Measle Vaccine Revenue by Type (2017-2028)
7.2 Europe Measle Vaccine Market Size by Application
7.2.1 Europe Measle Vaccine Sales by Application (2017-2028)
7.2.2 Europe Measle Vaccine Revenue by Application (2017-2028)
7.3 Europe Measle Vaccine Market Size by Country
7.3.1 Europe Measle Vaccine Sales by Country (2017-2028)
7.3.2 Europe Measle Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Measle Vaccine Market Size by Type
8.1.1 Asia Pacific Measle Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Measle Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Measle Vaccine Market Size by Application
8.2.1 Asia Pacific Measle Vaccine Sales by Application (2017-2028)
8.2.2 Asia Pacific Measle Vaccine Revenue by Application (2017-2028)
8.3 Asia Pacific Measle Vaccine Market Size by Region
8.3.1 Asia Pacific Measle Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Measle Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Measle Vaccine Market Size by Type
9.1.1 Latin America Measle Vaccine Sales by Type (2017-2028)
9.1.2 Latin America Measle Vaccine Revenue by Type (2017-2028)
9.2 Latin America Measle Vaccine Market Size by Application
9.2.1 Latin America Measle Vaccine Sales by Application (2017-2028)
9.2.2 Latin America Measle Vaccine Revenue by Application (2017-2028)
9.3 Latin America Measle Vaccine Market Size by Country
9.3.1 Latin America Measle Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Measle Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Measle Vaccine Market Size by Type
10.1.1 Middle East and Africa Measle Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Measle Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Measle Vaccine Market Size by Application
10.2.1 Middle East and Africa Measle Vaccine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Measle Vaccine Revenue by Application (2017-2028)
10.3 Middle East and Africa Measle Vaccine Market Size by Country
10.3.1 Middle East and Africa Measle Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Measle Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Overview
11.1.3 Merck Measle Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Merck Measle Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 Biovac
11.2.1 Biovac Corporation Information
11.2.2 Biovac Overview
11.2.3 Biovac Measle Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Biovac Measle Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Biovac Recent Developments
11.3 McKesson Medical
11.3.1 McKesson Medical Corporation Information
11.3.2 McKesson Medical Overview
11.3.3 McKesson Medical Measle Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 McKesson Medical Measle Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 McKesson Medical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Measle Vaccine Industry Chain Analysis
12.2 Measle Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Measle Vaccine Production Mode & Process
12.4 Measle Vaccine Sales and Marketing
12.4.1 Measle Vaccine Sales Channels
12.4.2 Measle Vaccine Distributors
12.5 Measle Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Measle Vaccine Industry Trends
13.2 Measle Vaccine Market Drivers
13.3 Measle Vaccine Market Challenges
13.4 Measle Vaccine Market Restraints
14 Key Findings in The Global Measle Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Measle Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Inactivated Vaccine
    Table 3. Major Manufacturers of Attenuated Vaccine
    Table 4. Global Measle Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Measle Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Measle Vaccine Sales by Region (2017-2022) & (K Units)
    Table 7. Global Measle Vaccine Sales Market Share by Region (2017-2022)
    Table 8. Global Measle Vaccine Sales by Region (2023-2028) & (K Units)
    Table 9. Global Measle Vaccine Sales Market Share by Region (2023-2028)
    Table 10. Global Measle Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Measle Vaccine Revenue Market Share by Region (2017-2022)
    Table 12. Global Measle Vaccine Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Measle Vaccine Revenue Market Share by Region (2023-2028)
    Table 14. Global Measle Vaccine Sales by Manufacturers (2017-2022) & (K Units)
    Table 15. Global Measle Vaccine Sales Share by Manufacturers (2017-2022)
    Table 16. Global Measle Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Measle Vaccine Revenue Share by Manufacturers (2017-2022)
    Table 18. Measle Vaccine Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 19. Global Measle Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Measle Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Measle Vaccine as of 2021)
    Table 21. Measle Vaccine Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Measle Vaccine Product Offered
    Table 23. Date of Manufacturers Enter into Measle Vaccine Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Measle Vaccine Sales by Type (2017-2022) & (K Units)
    Table 26. Global Measle Vaccine Sales by Type (2023-2028) & (K Units)
    Table 27. Global Measle Vaccine Sales Share by Type (2017-2022)
    Table 28. Global Measle Vaccine Sales Share by Type (2023-2028)
    Table 29. Global Measle Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Measle Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Measle Vaccine Revenue Share by Type (2017-2022)
    Table 32. Global Measle Vaccine Revenue Share by Type (2023-2028)
    Table 33. Measle Vaccine Price by Type (2017-2022) & (USD/Unit)
    Table 34. Global Measle Vaccine Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 35. Global Measle Vaccine Sales by Application (2017-2022) & (K Units)
    Table 36. Global Measle Vaccine Sales by Application (2023-2028) & (K Units)
    Table 37. Global Measle Vaccine Sales Share by Application (2017-2022)
    Table 38. Global Measle Vaccine Sales Share by Application (2023-2028)
    Table 39. Global Measle Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Measle Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Measle Vaccine Revenue Share by Application (2017-2022)
    Table 42. Global Measle Vaccine Revenue Share by Application (2023-2028)
    Table 43. Measle Vaccine Price by Application (2017-2022) & (USD/Unit)
    Table 44. Global Measle Vaccine Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 45. North America Measle Vaccine Sales by Type (2017-2022) & (K Units)
    Table 46. North America Measle Vaccine Sales by Type (2023-2028) & (K Units)
    Table 47. North America Measle Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Measle Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Measle Vaccine Sales by Application (2017-2022) & (K Units)
    Table 50. North America Measle Vaccine Sales by Application (2023-2028) & (K Units)
    Table 51. North America Measle Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Measle Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Measle Vaccine Sales by Country (2017-2022) & (K Units)
    Table 54. North America Measle Vaccine Sales by Country (2023-2028) & (K Units)
    Table 55. North America Measle Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Measle Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Measle Vaccine Sales by Type (2017-2022) & (K Units)
    Table 58. Europe Measle Vaccine Sales by Type (2023-2028) & (K Units)
    Table 59. Europe Measle Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Measle Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Measle Vaccine Sales by Application (2017-2022) & (K Units)
    Table 62. Europe Measle Vaccine Sales by Application (2023-2028) & (K Units)
    Table 63. Europe Measle Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Measle Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Measle Vaccine Sales by Country (2017-2022) & (K Units)
    Table 66. Europe Measle Vaccine Sales by Country (2023-2028) & (K Units)
    Table 67. Europe Measle Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Measle Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Measle Vaccine Sales by Type (2017-2022) & (K Units)
    Table 70. Asia Pacific Measle Vaccine Sales by Type (2023-2028) & (K Units)
    Table 71. Asia Pacific Measle Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Measle Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Measle Vaccine Sales by Application (2017-2022) & (K Units)
    Table 74. Asia Pacific Measle Vaccine Sales by Application (2023-2028) & (K Units)
    Table 75. Asia Pacific Measle Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Measle Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Measle Vaccine Sales by Region (2017-2022) & (K Units)
    Table 78. Asia Pacific Measle Vaccine Sales by Region (2023-2028) & (K Units)
    Table 79. Asia Pacific Measle Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Measle Vaccine Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Measle Vaccine Sales by Type (2017-2022) & (K Units)
    Table 82. Latin America Measle Vaccine Sales by Type (2023-2028) & (K Units)
    Table 83. Latin America Measle Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Measle Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Measle Vaccine Sales by Application (2017-2022) & (K Units)
    Table 86. Latin America Measle Vaccine Sales by Application (2023-2028) & (K Units)
    Table 87. Latin America Measle Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Measle Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Measle Vaccine Sales by Country (2017-2022) & (K Units)
    Table 90. Latin America Measle Vaccine Sales by Country (2023-2028) & (K Units)
    Table 91. Latin America Measle Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Measle Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Measle Vaccine Sales by Type (2017-2022) & (K Units)
    Table 94. Middle East and Africa Measle Vaccine Sales by Type (2023-2028) & (K Units)
    Table 95. Middle East and Africa Measle Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Measle Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Measle Vaccine Sales by Application (2017-2022) & (K Units)
    Table 98. Middle East and Africa Measle Vaccine Sales by Application (2023-2028) & (K Units)
    Table 99. Middle East and Africa Measle Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Measle Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Measle Vaccine Sales by Country (2017-2022) & (K Units)
    Table 102. Middle East and Africa Measle Vaccine Sales by Country (2023-2028) & (K Units)
    Table 103. Middle East and Africa Measle Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Measle Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Merck Corporation Information
    Table 106. Merck Description and Major Businesses
    Table 107. Merck Measle Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 108. Merck Measle Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Merck Recent Developments
    Table 110. Biovac Corporation Information
    Table 111. Biovac Description and Major Businesses
    Table 112. Biovac Measle Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 113. Biovac Measle Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Biovac Recent Developments
    Table 115. McKesson Medical Corporation Information
    Table 116. McKesson Medical Description and Major Businesses
    Table 117. McKesson Medical Measle Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 118. McKesson Medical Measle Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. McKesson Medical Recent Developments
    Table 120. Key Raw Materials Lists
    Table 121. Raw Materials Key Suppliers Lists
    Table 122. Measle Vaccine Distributors List
    Table 123. Measle Vaccine Customers List
    Table 124. Measle Vaccine Market Trends
    Table 125. Measle Vaccine Market Drivers
    Table 126. Measle Vaccine Market Challenges
    Table 127. Measle Vaccine Market Restraints
    Table 128. Research Programs/Design for This Report
    Table 129. Key Data Information from Secondary Sources
    Table 130. Key Data Information from Primary Sources
List of Figures
    Figure 1. Measle Vaccine Product Picture
    Figure 3. Global Measle Vaccine Market Share by Type in 2021 & 2028
    Figure 3. Inactivated Vaccine Product Picture
    Figure 4. Attenuated Vaccine Product Picture
    Figure 5. Global Measle Vaccine Market Share by Application in 2021 & 2028
    Figure 6. Hospital
    Figure 7. Scientific Research
    Figure 8. Others
    Figure 9. Measle Vaccine Report Years Considered
    Figure 10. Global Measle Vaccine Sales 2017-2028 (K Units)
    Figure 11. Global Measle Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Measle Vaccine Revenue 2017-2028 (US$ Million)
    Figure 13. Global Measle Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Measle Vaccine Sales Market Share by Region (2017-2022)
    Figure 15. Global Measle Vaccine Sales Market Share by Region (2023-2028)
    Figure 16. North America Measle Vaccine Sales YoY (2017-2028) & (K Units)
    Figure 17. North America Measle Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe Measle Vaccine Sales YoY (2017-2028) & (K Units)
    Figure 19. Europe Measle Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific Measle Vaccine Sales YoY (2017-2028) & (K Units)
    Figure 21. Asia-Pacific Measle Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America Measle Vaccine Sales YoY (2017-2028) & (K Units)
    Figure 23. Latin America Measle Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa Measle Vaccine Sales YoY (2017-2028) & (K Units)
    Figure 25. Middle East & Africa Measle Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The Measle Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of Measle Vaccine in the World: Market Share by Measle Vaccine Revenue in 2021
    Figure 28. Global Measle Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global Measle Vaccine Sales Market Share by Type (2017-2028)
    Figure 30. Global Measle Vaccine Revenue Market Share by Type (2017-2028)
    Figure 31. Global Measle Vaccine Sales Market Share by Application (2017-2028)
    Figure 32. Global Measle Vaccine Revenue Market Share by Application (2017-2028)
    Figure 33. North America Measle Vaccine Sales Market Share by Type (2017-2028)
    Figure 34. North America Measle Vaccine Revenue Market Share by Type (2017-2028)
    Figure 35. North America Measle Vaccine Sales Market Share by Application (2017-2028)
    Figure 36. North America Measle Vaccine Revenue Market Share by Application (2017-2028)
    Figure 37. North America Measle Vaccine Sales Share by Country (2017-2028)
    Figure 38. North America Measle Vaccine Revenue Share by Country (2017-2028)
    Figure 39. U.S. Measle Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada Measle Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe Measle Vaccine Sales Market Share by Type (2017-2028)
    Figure 42. Europe Measle Vaccine Revenue Market Share by Type (2017-2028)
    Figure 43. Europe Measle Vaccine Sales Market Share by Application (2017-2028)
    Figure 44. Europe Measle Vaccine Revenue Market Share by Application (2017-2028)
    Figure 45. Europe Measle Vaccine Sales Share by Country (2017-2028)
    Figure 46. Europe Measle Vaccine Revenue Share by Country (2017-2028)
    Figure 47. Germany Measle Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 48. France Measle Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. Measle Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy Measle Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia Measle Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific Measle Vaccine Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Measle Vaccine Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Measle Vaccine Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Measle Vaccine Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Measle Vaccine Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific Measle Vaccine Revenue Share by Region (2017-2028)
    Figure 58. China Measle Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan Measle Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea Measle Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 61. India Measle Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia Measle Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 63. Taiwan Measle Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia Measle Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand Measle Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia Measle Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 67. Philippines Measle Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 68. Latin America Measle Vaccine Sales Market Share by Type (2017-2028)
    Figure 69. Latin America Measle Vaccine Revenue Market Share by Type (2017-2028)
    Figure 70. Latin America Measle Vaccine Sales Market Share by Application (2017-2028)
    Figure 71. Latin America Measle Vaccine Revenue Market Share by Application (2017-2028)
    Figure 72. Latin America Measle Vaccine Sales Share by Country (2017-2028)
    Figure 73. Latin America Measle Vaccine Revenue Share by Country (2017-2028)
    Figure 74. Mexico Measle Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 75. Brazil Measle Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 76. Argentina Measle Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 77. Middle East and Africa Measle Vaccine Sales Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Measle Vaccine Revenue Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Measle Vaccine Sales Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Measle Vaccine Revenue Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Measle Vaccine Sales Share by Country (2017-2028)
    Figure 82. Middle East and Africa Measle Vaccine Revenue Share by Country (2017-2028)
    Figure 83. Turkey Measle Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 84. Saudi Arabia Measle Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 85. U.A.E Measle Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 86. Measle Vaccine Value Chain
    Figure 87. Measle Vaccine Production Process
    Figure 88. Channels of Distribution
    Figure 89. Distributors Profiles
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Accenture

RELATED REPORTS

Global Vaccine Temperature Monitoring System Market Insights Forecast to 2028
Global Vaccine Temperature Monitoring System Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-10F7540
Fri May 13 00:00:00 UTC 2022

Add to Cart

Global Nelfinavir Market Insights Forecast to 2028
Global Nelfinavir Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-25I7469
Fri May 13 00:00:00 UTC 2022

Add to Cart

Global Vancomycin Market Insights and Forecast to 2028
Global Vancomycin Market Insights and Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-20N7760
Tue May 03 00:00:00 UTC 2022

Add to Cart

Global Hepatitis B Human Immunoglobulin Market Insights and Forecast to 2028
Global Hepatitis B Human Immunoglobulin Market Insights and Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-22V7718
Tue May 03 00:00:00 UTC 2022

Add to Cart